Karl Pfleger
@KarlPfleger
Founder of nonprofit http://AgingBiotech.info Investor in rejuvenation startups: portfolio on LinkedIn Organizer of http://VitaminDforAll.org AI/ML Stanford PhD & ex-Google
One of the most exciting thing happening in the aging/longevity field that too few people discuss is that the aggregate pipeline of the entire sector has hit the exciting point where things are trickling thru to FDA approval & many more are on the way. My talk recently posted.

My new op-ed on how to productively move past the is-aging-a-disease debates.
Karl Pfleger calls time on the aging debate, and advocates for focus on aging’s indication status, subpathologies and clinical significance. longevity.technology/news/is-aging-… #longevity #aging #healthinnovation #biotech #futureofmedicine
Wouldn't it be just as reasonable to call fasting mimicking (diet) instead intermittent calorie restriction? In analogy with IF as acronym, it could be ICR instead of FMD.